Cargando…
The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain
Neridronate or ((6-amino-1-hydroxy-1-phosphonohexyl) phosphonic acid) is an amino-bisphosphonate (BP) synthetized in Italy in 1986. Bisphosphonates are molecules with a P-C-P bond in their structure that allows strong and selectively binding to hydroxyapatite (HAP) as well as osteoclasts inhibition...
Autores principales: | Iolascon, Giovanni, Moretti, Antimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267106/ https://www.ncbi.nlm.nih.gov/pubmed/35805927 http://dx.doi.org/10.3390/ijms23136921 |
Ejemplares similares
-
Challenges and Solutions for Musculoskeletal Disorders in Athletes
por: Iolascon, Giovanni, et al.
Publicado: (2022) -
Myths and Truths about Placebo Effect in Rehabilitation for Musculoskeletal Pain
por: Iolascon, Giovanni, et al.
Publicado: (2021) -
Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study
por: Moretti, Antimo, et al.
Publicado: (2022) -
Epidemiology of Musculoskeletal Injuries in Adult Athletes: A Scoping Review
por: Gimigliano, Francesca, et al.
Publicado: (2021) -
A Review of Aceclofenac: Analgesic and Anti-Inflammatory Effects on Musculoskeletal Disorders
por: Iolascon, Giovanni, et al.
Publicado: (2021)